Introduction

Just Classifying Emerging Compounds

Just Classifying Emerging Compounds

← Back to Just Science Podcast

Original Release Date: July 2, 2018

In episode eleven of our 2018 Drugs Season, Just Science visits Atlanta for the 45th Annual ASCLD symposium to visit with Dr. Barry Logan, Sr. Vice President of Forensic Science Initiatives and Chief of Forensic Toxicology at National Medical Services, to discuss the convergence of drivers of the national opioid epidemic. Follow along to learn what’s in these novel compounds, and why it matters to illicit drug manufacturers, regulatory agencies, and local crime labs.

This episode of Just Science is funded by the National Institute of Justice’s Forensic Technology Center of Excellence [Award 2016-MU-BX-K110].

Listen to or download the episode here:


Guest Biography

Dr. Barry K. Logan is Sr. Vice President of Forensic Science Initiatives, Chief Scientist, at NMS Labs in Willow Grove, Pennsylvania, where his responsibilities include management of toxicology resources, new test design and development, and expert testimony in forensic toxicology and chemistry. Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over one hundred (100) publications and four hundred (400) presentations in forensic toxicology and analytical chemistry, including work on the effects of methamphetamine, cocaine and marijuana on drivers, drug caused and related death. His recent work has focused on the analytical and interpretive toxicology of emerging recreational and designer drugs. Dr. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and Executive Director at the Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in suburban Philadelphia. He holds academic appointments at Indiana University, Arcadia University and Thomas Jefferson University. In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and in 2013-14 served as President of the American Academy of Forensic Sciences (AAFS).


The opinions, findings, and conclusions or recommendations expressed in this podcast episode are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Evaluating a Statistical Method for Comparison of Mass Spectra of Novel Psychoactive Substance

← Back to Webinar Series Page This webinar originally occurred on July 25, 2024 Duration: 1 hour Overview Identification of novel psychoactive substances (NPS) based on comparisons of electron-ionization (EI) mass spectra continues to pose challenges in seized drug analysis.…

LC-DAD with Optional ESI/MS: An Emerging Gold Standard for Hemp Compliance Testing

← Back to Webinar Series Page This webinar originally occurred on June 13, 2024 Duration: 1 hour Overview Hemp compliance testing is used to quantify total Δ9-tetrahydrocannabinol (Δ9-THC), including both Δ9-THC and its precursor, i.e., Δ9-tetrahydrocannabinolic acid (Δ9-THCA), to determine…